Human challenge trials are highly valued as one of the most efficient ways to evaluate the efficacy of novel vaccines and therapeutics.
Controlled human infection model (Chim) studies provide insight into diseases and can help determine vaccine efficacy with controlled conditions.
Challenge trials can significantly reduce the time taken for vaccine approval and have financial benefits.
The human participants in research may not actually know what they're getting themselves into.
[
add
]
[
|
|
...
]